Curosurf Warnings

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Warnings

Babies born following very prolonged rupture of the membranes (higher than 3 weeks) may not show optimal response to the exogenous surfactant. Surfactant administration can be expected to reduce the severity of RDS or the risk of its occurrence, but cannot be expected to completely eliminate mortality and morbidity associated with preterm birth, as preterm babies may be exposed to other complications due to their immaturity. The administration of CUROSURF to premature infants with renal or hepatic impairment has not been studied.

Manufacturer:

Chiesi

Distributor:

Firma Chun Cheong

Zenfields